Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Contemp Clin Trials. 2018 Aug 20;73:111–122. doi: 10.1016/j.cct.2018.08.004

Table 2:

STURDY Data Collection Schedule.

Months from randomization Pre-RZ RZ Year 1 Year 2
−2+ -2 −1 0 1 3 6 9 12 15 18 21 24
[C]linic, [T]elephone, or
[E]ither
E C C C T C T T C T T T C
Visit PS SV+ BV+ RZ F01 F03 F06 F09 F12 F15 F18 F21 F24
Consent O W W O
Prescreen questionnaire X
Registration (demographics,
eligibility questions)
X
Blood draw* X X X X X
Urine collection (stored) X X X X
Medical history, incl.
adverse events
X X X X X X X X X X X X
Cognitive testing$ X X X X
Physical measurements# X X X X
Short Physical Performance
Battery (SPPB)
X X X X
Timed Up and Go (TUG)
Test
X X X X
Accelerometry X X X X
6-minute walk X X X X
Grip strength X X X X
Physical function
questionnaire+
X X X X
Physical activity
questionnaire+
X X X X
Vitamin D and calcium food
frequency questionnaire+
X
SF-12 health survey+ X X
Adherence reminders X X X X X X X X X X X
Fall calendar RI^ X X X X X X X X X X
Pill distribution/return RI^ X M M M X M M M X

Abbreviations: RZ=Randomization Visit; PS=Pre-screening; SV=Screening Visit; BV=Baseline Visit; Fxx=Follow-up visit; O=oral; W=written; RI=run-in; M=by mail;

+

physical assessments and questionnaires can be completed at either SV or BV, as long as they are completed prior to RZ

*

real-time 25(OH)D and calcium; stored blood

$

MMSE at screening visit; Mini-Cog® at follow-up visits

#

height (baseline only), weight, blood pressure, including orthostatic blood pressure, and heart rate

^

at the end of BV, the participant will be given placebo pills and instructed to take one daily and complete the pill/fall calendar for a period of about 10 days, which the participant will return at RZ